A detailed history of Cerity Partners LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cerity Partners LLC holds 611,784 shares of CORT stock, worth $35.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
611,784
Previous 675,554 9.44%
Holding current value
$35.2 Million
Previous $21.9 Million 28.95%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$29.51 - $46.26 $1.88 Million - $2.95 Million
-63,770 Reduced 9.44%
611,784 $28.3 Million
Q2 2024

Aug 13, 2024

SELL
$22.21 - $34.48 $6,418 - $9,964
-289 Reduced 0.04%
675,554 $21.9 Million
Q1 2024

May 14, 2024

BUY
$21.1 - $27.46 $12.7 Million - $16.5 Million
601,776 Added 812.48%
675,843 $17 Million
Q4 2023

Jan 26, 2024

SELL
$24.82 - $32.88 $10.8 Million - $14.3 Million
-436,175 Reduced 85.48%
74,067 $2.41 Million
Q3 2023

Nov 13, 2023

BUY
$21.97 - $33.8 $11.2 Million - $17.2 Million
510,242 New
510,242 $13.9 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.